Health CanadaGeneral Alert
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
Published: April 29, 2020Recall ID: 63371Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
Additional Source Details
| Field | Value |
|---|---|
| N I D | 63371 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/importation-us-labelled-pancuronium-bromide-injection-due-shortage-neuromuscular |
| Issue | Product safety |
| Title | Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2020-04-29 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products Check if your household is affected: https://therecallfile.com/recalls/importation-of-us-labelled-pancuronium-bromide-injection-due-to-shorta/CANADA-63371
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordImportation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products